Loading...
Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer
The receptor tyrosine kinase HER2 is overexpressed in approximately 25% of breast cancers. HER2 acts as a signal amplifier for its siblings, namely three different transmembrane receptors that collectively bind with 11 distinct growth factors of the EGF family. Thus, overexpression of HER2 confers a...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3038194/ https://ncbi.nlm.nih.gov/pubmed/20951604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.critrevonc.2010.09.002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|